Non-Invasive ultrasound stimulation is an emerging techniques which can noninvasively inhibit or excite neural activity in the targeted brain by delivering of pulsed ultrasonic waves. Non-Invasive ultrasound stimulation is an emerging approach which combines noninvasiveness with the focus which is relatively sharp even in the deep brain region.
Non-Invasive ultrasound stimulation is valuable to modulate specific nuclei or neuronal pathways in clinical and basic neurosciences. Non-Invasive ultrasound stimulation also have therapeutic potential in neurological disease such as Alzheimer's disease, epilepsy, and stroke.
Non-Invasive ultrasound stimulation have the potential to transform the treatment through gaining access into the deep brain without damaging tissue, allow the reversible opening of the blood-brain barrier to deliver therapeutic agents to targeted diseased areas and ablate targeted tissue without exposing the brain to the effects of ionizing radiation and. Non-Invasive ultrasound stimulation have huge potential in its capacity to open the blood- brain barrier which allow drug delivery to the brain.
Increasing prevalence of neurological disorders, increasing baby boomer population associated with brain disorders are major factor which drive the Non-Invasive ultrasound stimulation market. Increasing clinical research and rising FDA approval for novel techniques for the treatment of neurological disorder is expected to fuel the non-invasive ultrasound stimulation in the near future.
Growing demand of non-invasive ultrasound stimulation in early stage, noninvasive technology have the huge potential which improve the quality of life and decreased cost of care for Alzheimer’s patient drive the non-invasive ultrasound stimulation market .
Development of promising techniques which further enhance the delivery of therapeutic drugs or antibodies to brain. However, certain factor such as limited penetrability to reach deep brain structures and high cost associated with the non-invasive ultrasound stimulation is expected to hinder the growth of non-invasive ultrasound stimulation market.
Examples of some of the key manufacturer present in the global non-invasive ultrasound stimulation market are BrainSonix Corporation, Sonacare Medical, Sonic Concepts, Inc. among others.
Know More Details About the Report
The report covers exhaustive analysis on,
- Non-Invasive ultrasound stimulation Market Segments
- Non-Invasive ultrasound stimulation Market Dynamics
- Historical Actual Market Size, 2012 – 2016
- Non-Invasive ultrasound stimulation Market Size & Forecast 2016 to 2024
- Non-Invasive ultrasound stimulation Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Non-Invasive ultrasound stimulation Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Asia Pacific Excluding China
- Middle East & Africa
Avail customized purchase options for your needs
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
The global non-invasive ultrasound stimulation market is segmented on basis of application, modality, end user and geography.
- Segmentation by Application
- Alzheimer's Disease
- Brain Tumors
- Parkinson's disease
- Segmentation by Modality
- Bench Top
- Segmentation by End User
- Ambulatory surgical centers
- Diagnostic Centers
- Specialty Clinics
Promising preclinical studies and research to show huge potential and enhance delivery of drugs to brain. Increased funding by the government and increased research and development spur the market of non-invasive ultrasound stimulation. Development in new novel therapy for various neurological disease further drive the market growth of non-invasive ultrasound stimulation. Growing number of end user such as hospitals and specialty clinics in developing and under developed nation’s further drive the non-invasive ultrasound stimulation market. Furthermore growing number of physicians and technicians will spur the non-invasive ultrasound stimulation market.
The North America is expected to retain its dominance in the non-invasive ultrasound stimulation market, owing to growing prevalence of neurological disorders, presence of various key players and increasing adoption of new technology for the treatment of neurological disease. According to Centers for Disease Control and Prevention, out of total population of US, 1.2% have active epilepsy in 2015 which is about 3.4 Mn people with epilepsy i.e. 3 million adults and 470,000 children. Europe is expected to contribute for the second largest revenue share after North America in the global non-invasive ultrasound stimulation market, owing increasing demand of minimally invasive and noninvasive technology for treating neurological disorder and growing approval for new techniques and technology. Undergoing clinical research and favorable reimbursement for the neurological disease is further expected to drive the Europe non-invasive ultrasound stimulation market in the near future. Asia Pacific is expected to show rapid growth, due increased prevalence and awareness of neurological disorders provide huge potential along with the growing healthcare expenditure and increasing number of end user segment such as specialty clinics and hospitals. Adoption of new technology and fast-paced progresses in healthcare infrastructure is expected to drive the non-invasive ultrasound stimulation market in the forecast period. China is expected to register fast growth, due presence of huge patient pool affected by Alzheimer's disease and surge in elderly population along with the changing regulatory environment, and favorable reimbursement scenarios. Latin America and Middle East & Africa are projected to exhibit limited growth in non-invasive ultrasound stimulation market, due to less available treatment options for treating neurological disorder.
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.